Neonatal sepsis can be classified into two subtypes depending upon whether the onset of
symptoms is before 72 hours of life (early‐onset neonatal sepsis—EONS) or later (late …

Background Adverse events from intrapartum antibiotic prophylaxis (IAP) are poorly
documented yet essential to inform clinical practice for neonatal group B Streptococcus …

Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease
since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the …

OBJECTIVE: To estimate the cost and consequences of intrapartum polymerase chain
reaction (PCR) screening on early-onset group B streptococcal (GBS) disease compared …

The objective of this study was to determine the reliability of the real-time PCR assay for
determining the group B Streptococcus (GBS) status of women in labor. In this prospective …

Background Introducing neonatal screening procedures may not be readily accepted by
parents and may increase anxiety. The acceptability of pulse oximetry screening to parents …

BACKGROUND Group B streptococcal infections are the leading cause of sepsis and
meningitis in newborns. A rapid and reliable method for the detection of this pathogen at the …

Objectives To estimate the potential impact of the addition of culture-based screening for
group B streptococcus (GBS) carriage in pregnancy to a risk-based prevention policy in the …

Background Intrapartum chemoprophylaxis reduces early‐onset group B streptococcal
disease (EOGBSD) in newborns. Some guidelines advise that intrapartum antibiotics should …

The maternal pregnancy microbiome (including genitourinary and gut) has been linked to
important pregnancy/birth and later childhood health outcomes. However, such sampling as …